Jacques Col
Cliniques Universitaires Saint-Luc
9 Papers
128 Citations
Jacques Col is an academic researcher from Cliniques Universitaires Saint-Luc. The author has contributed to research in topics: Cardiogenic shock & Cardiac output. The author has an hindex of 6, co-authored 9 publications. Previous affiliations of Jacques Col include Columbia University.
Chat about Author
Papers
Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on Mortality Results of an International Registry
Judith S. Hochman,Judith S. Hochman,Jean Boland,Lynn A. Sleeper,Mark Porway,Jeffrey Brinker,Jacques Col,Alice K. Jacobs,James Slater,David Miller,Hal S. Wasserman,Mark Menegus,J. David Talley,Sonja M. McKinlay,Timothy A. Sanborn,Thierry H. LeJemtel +15 more
TL;DR: In this article, the authors examined the current spectrum of cardiogenic shock, the proportion of patients who are potential candidates for a trial of early revascularization, and the apparent impact on mortality of patients with acute myocardial infarction.
373
Amrinone in the management of low cardiac output after open heart surgery
TL;DR: Hemodynamic effects of amrinone were studied in 2 groups of patients after open heart surgery and significant beneficial changes were noted in CI, PCWP, right atrial pressure, systemic vascular resistance and pulmonary vascular resistance.
104
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin - Outcomes at 6 months and 1 year in the SYNERGY trial
Kenneth W. Mahaffey,Marc Cohen,Jyotsna Garg,Elliott M. Antman,Neal S. Kleiman,Shaun G. Goodman,Lisa G. Berdan,Craig J. Reist,Anatoly Langer,Harvey D. White,Philip E. Aylward,Jacques Col,James J. Ferguson,Robert M. Califf +13 more
TL;DR: The SYNERGY trial showed that enoxaparin was not inferior to unfractionated heparin in reducing death or nonfatal myocardial infarction (MI) at 30 days, and patients continued to experience adverse cardiac events through long-term follow-up.
72
Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment.
TL;DR: Oral ibopamine shows promise in the treatment of congestive heart failure, but more extensive studies after chronic treatment are desirable.
21
Amrinone in the Management of Low Cardiac Output After Open Heart Surgery
TL;DR: In this paper, Amrinone was administered 24 hours postoperatively by bolus injection (2 mg/kg) and by 12-hour infusions (20 μg/kg/min).
7